ATR (AptarGroup) Beneish M-Score: -2.61 (As of Jun. 26, 2026)


ATR AptarGroup Inc ATR
82 GF Score
Price $126.43
GF Value $157.01
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is AptarGroup Beneish M-Score?

AptarGroup ATR +1.73% 82 Beneish M-Score is -2.61 as of Jun. 26, 2026. GuruFocus rates ATR with a GF Score™ of 82/100 and a GF Value™ of $157.01 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 766 Medical Devices & Instruments companies, AptarGroup ranks better than 53.39% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.61 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for AptarGroup's Beneish M-Score or its related term are showing as below:

ATR' s Beneish M-Score Range Over the Past 10 Years
Min: -2.85   Med: -2.67   Max: -2.06
Current: -2.61

During the past 13 years, the highest Beneish M-Score of AptarGroup was -2.06. The lowest was -2.85. And the median was -2.67.


AptarGroup Beneish M-Score Historical Data

* Premium members only.

The historical data trend for AptarGroup's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AptarGroup Beneish M-Score Chart

AptarGroup Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.40 -2.73 -2.76 -2.76 -2.50

AptarGroup Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.71 -2.59 -2.49 -2.50 -2.61

ATR vs RGEN, AVTR, TFX: Beneish M-Score Comparison

For the Medical Instruments & Supplies subindustry, AptarGroup's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AptarGroup Beneish M-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AptarGroup's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where AptarGroup's Beneish M-Score falls into.


ATR
82GF Score
AptarGroup Inc ATR
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AptarGroup Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of AptarGroup for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0298+0.528 * 1.0427+0.404 * 0.9781+0.892 * 1.0895+0.115 * 0.9884
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9714+4.679 * -0.047134-0.327 * 1.098
=-2.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $833 Mil.
Revenue was 982.868 + 962.736 + 961.131 + 966.009 = $3,873 Mil.
Gross Profit was 351.909 + 338.221 + 363.085 + 367.015 = $1,420 Mil.
Total Current Assets was $1,768 Mil.
Total Assets was $5,098 Mil.
Property, Plant and Equipment(Net PPE) was $1,722 Mil.
Depreciation, Depletion and Amortization(DDA) was $297 Mil.
Selling, General, & Admin. Expense(SGA) was $619 Mil.
Total Current Liabilities was $1,063 Mil.
Long-Term Debt & Capital Lease Obligation was $1,187 Mil.
Net Income was 72.674 + 74.344 + 127.927 + 111.72 = $387 Mil.
Non Operating Income was -1.511 + -6.378 + 26.168 + 2.712 = $21 Mil.
Cash Flow from Operations was 118.694 + 183.693 + 177.606 + 125.958 = $606 Mil.
Total Receivables was $743 Mil.
Revenue was 887.305 + 848.088 + 909.291 + 910.063 = $3,555 Mil.
Gross Profit was 336.414 + 329.414 + 350.78 + 342.623 = $1,359 Mil.
Total Current Assets was $1,512 Mil.
Total Assets was $4,527 Mil.
Property, Plant and Equipment(Net PPE) was $1,556 Mil.
Depreciation, Depletion and Amortization(DDA) was $265 Mil.
Selling, General, & Admin. Expense(SGA) was $585 Mil.
Total Current Liabilities was $1,208 Mil.
Long-Term Debt & Capital Lease Obligation was $612 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(833.268 / 3872.744) / (742.703 / 3554.747)
=0.215162 / 0.208933
=1.0298

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1359.231 / 3554.747) / (1420.23 / 3872.744)
=0.382371 / 0.366724
=1.0427

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1768.272 + 1722.163) / 5097.783) / (1 - (1511.767 + 1555.965) / 4527.088)
=0.315303 / 0.322361
=0.9781

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3872.744 / 3554.747
=1.0895

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(265.082 / (265.082 + 1555.965)) / (297.441 / (297.441 + 1722.163))
=0.145566 / 0.147277
=0.9884

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(618.822 / 3872.744) / (584.723 / 3554.747)
=0.159789 / 0.164491
=0.9714

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1187.383 + 1063.033) / 5097.783) / ((612.015 + 1208.024) / 4527.088)
=0.44145 / 0.402033
=1.098

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(386.665 - 20.991 - 605.951) / 5097.783
=-0.047134

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

AptarGroup has a M-score of -2.61 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.61 mean?
AptarGroup (ATR) has a Beneish M-Score of -2.61 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on AptarGroup and its competitors. According to the industry distribution chart, AptarGroup ranks #357 out of 766 companies in the Medical Devices & Instruments industry, placing it in the top 46.6%.
Is AptarGroup's Beneish M-Score too high?
AptarGroup's current Beneish M-Score is -2.61. Based on the distribution chart, AptarGroup ranks #357 out of 766 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, AptarGroup has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AptarGroup's Beneish M-Score compare to RGEN and AVTR?
According to the Medical Devices & Instruments industry distribution chart, AptarGroup ranks #357 out of 766 companies for Beneish M-Score. This puts AptarGroup in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on AptarGroup and its competitors. AptarGroup's current Beneish M-Score is -2.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AptarGroup stock overvalued right now?
Based on GuruFocus' analysis, AptarGroup (ATR) is currently considered Modestly Undervalued. The stock's GF Value™ is $157.01, compared to a current price of $126.43 — trading 19.5% below its estimated fair value. The current Beneish M-Score is -2.61. AptarGroup's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For AptarGroup (ATR), the current Beneish M-Score is -2.61 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AptarGroup (ATR) Overvalued in 2026?

Based on GuruFocus' analysis, AptarGroup stock appears to be undervalued. The current stock price of $126.43 is trading 19.5% below its estimated GF Value™ of $157.01. GuruFocus considers AptarGroup to be Modestly Undervalued.

Key valuation signals for ATR:

  • Beneish M-Score: -2.61
  • GF Value™: $157.01 vs. price of $126.43 (19.5% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the ATR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AptarGroup Business Description

Other Exchanges AGT:Germany
Address 265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. Its sales are primarily from Europe (49% of sales) and the United States (28%), with China contributing 5% and other countries contributing 17%. It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
82GF Score

Get the complete analysis for ATR

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$126.43
Price
$157.01
GF Value